Protein and Peptide Therapeutics
- 1st Edition, Volume 212 - March 25, 2025
- Latest edition
- Editor: David B. Teplow
- Language: English
Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is writte… Read more
Robotics & automation week
Empowering Progress
Up to 20% on Robotics and Automation Resources!
- Provides the latest information on protein and peptide therapeutics research
- Offers outstanding and original reviews on a range of protein and peptide therapeutics research topics
- Serves as an indispensable reference for researchers and students alike
- Presents the latest release in the Progress in Molecular Biology and Translational Science series
David Teplow
1. Targeting Myc with protein drugs
Jumi Shin
2. Peptide-Based Inhibitors of Epigenetic Proteins
Jasmin Mecinovic and Jordi Hintzen
3. TBA
Charles Chen
4. Peptide Pharmacology: Pioneering Interventions for Alcohol Use Disorder
Abilash Valsala Gopalakrishnan, Ramkumar Katturajan and Sabina Evan Prince
5. Peptides on Patrol: Carrier Systems for Targeted Delivery
Vivek P. Chavda
6. Daptomycin: Mechanism of Action, Mechanisms of Resistance, Synthesis and Structure-activity Relationships
Scott Taylor and Ryan Moreira
7. Delivery of Protein Therapeutics and Vaccines Using their Multivalent Complexes with Synthetic Polyelectrolytes
Alexander K. Andrianov
8. Delivery of Therapeutic Proteins to Ocular Tissues: Barriers, Approaches, Regulatory Considerations and Future Perspectives
Divyesh Harshadkumar Shastri
9. TBA
Gopal Singh Bisht
10. Peptidomimetics Design and Characterization: Bridging Experimental and Computer-Based Approaches
Daniele Di Marino, ALICE ROMAGNOLI and Domenico Raimondo
11. Vaccines Reimagined: The Peptide Revolution in Disease Prevention
Vivek P. Chavda
12. Surface Modified Proteins and Peptides: A new arm of targeted drug delivery
Vivek P. Chavda
13. Oral Delivery of Protein and Peptide
Vivek P. Chavda and Pankti Balar
- Edition: 1
- Latest edition
- Volume: 212
- Published: March 25, 2025
- Language: English
DT
David B. Teplow
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.